RESUMEN
OBJECTIVES: Kidney transplant is the best choice for treatment of patients with advanced chronic renal disease. However, small, poorly compliant, and unstable bladders can result in major problems for patients. Here, we aimed to develop and evaluate a new ileobladder model. MATERIALS AND METHODS: Fifteen rats (250-300 g) and 5 pigs (~100 kg) were cared for according to institutional and published guidelines. After general anesthesia, laparotomy was done through midline incision. Ileal loops were prepared for ileobladder. After cystectomy (0.5 cm above the trigone in rats, 1 cm above the trigone in pigs), anastomoses were done between antimesenteric sides of ileal loops and bladder remnant with 6/0 Prolene suture. Three other pigs received simultaneous renal transplant. RESULTS: One rat died on day 1 postsurgery from multiorgan hemorrhage. Two rats survived for 5 days, 3 rats for 7 days, and 3 rats for 11 days; 6 rats were killed for pathologic evaluation after 3 months. One pig survived for 22 days and 1 for 9 days. Of the 3 pigs that received a simultaneous renal transplant, 2 pigs were alive and doing well 80 and 72 days after surgery with normal urinary discharge (1 pig was killed for pathologic evaluation after 3 days). When ileobladder was opened, complete recovery of the anastomosis line was observed. Pathologic examination of the anastomosis sites reported a normal healing process with moderate inflammation and the muscular wall of the intestine showed hypertrophia that nearly reached the size of the bladder muscularis propria. CONCLUSIONS: Although we had some complications because no draining procedure was used, in terms of technique, our new ileobladder model is promising for providing functional bladder volume. A larger scale series in the clinical setting is planned. This technique can be useful for small bladders and bladder physiology disorders.
Asunto(s)
Íleon/cirugía , Trasplante de Riñón , Vejiga Urinaria/cirugía , Anastomosis Quirúrgica , Animales , Íleon/patología , Hemorragia Posoperatoria/etiología , Ratas , Recuperación de la Función , Sus scrofa , Factores de Tiempo , Vejiga Urinaria/patología , Vejiga Urinaria/fisiopatología , Micción , Cicatrización de HeridasRESUMEN
Lymphangioma of the ovary is a very rare tumor which is usually silent and identified incidentally at operation or autopsy. We report on a 61-year-old woman with lymphangioma of the ovary and review the relevant literature. The microscopic examination of the left ovary revealed numerous vascular spaces of different dimensions of which the inner surfaces were lined with flattened endothelial cells with neither cellular atypia nor extraluminal or intraluminal proliferation. There was no evidence of haemorrhage or necrosis. The stroma was formed by fibrocollagenous tissue infiltrated by rare lymphocytes. The cells lining vascular spaces were immunoreactive for CD31 by immunohistochemical staining.
Asunto(s)
Linfangioma/patología , Neoplasias Ováricas/patología , Femenino , Humanos , Histerectomía , Linfangioma/cirugía , Persona de Mediana Edad , Neoplasias Ováricas/cirugía , Ovariectomía , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/metabolismoAsunto(s)
Oclusión con Balón/efectos adversos , Técnicas Hemostáticas/efectos adversos , Enfermedad Aguda , Oclusión con Balón/instrumentación , Resultado Fatal , Hemorragia Gastrointestinal/terapia , Técnicas Hemostáticas/instrumentación , Humanos , Masculino , Persona de Mediana Edad , ParotiditisAsunto(s)
Adenocarcinoma/complicaciones , Migración de Cuerpo Extraño/diagnóstico por imagen , Obstrucción de la Salida Gástrica/terapia , Enfermedades del Íleon/etiología , Íleon , Obstrucción Intestinal/etiología , Cuidados Paliativos , Stents , Neoplasias Gástricas/complicaciones , Adenocarcinoma/cirugía , Adenocarcinoma/terapia , Anastomosis Quirúrgica , Diagnóstico Diferencial , Obstrucción de la Salida Gástrica/diagnóstico por imagen , Humanos , Enfermedades del Íleon/diagnóstico por imagen , Enfermedades del Íleon/cirugía , Íleon/diagnóstico por imagen , Íleon/cirugía , Obstrucción Intestinal/diagnóstico por imagen , Obstrucción Intestinal/cirugía , Masculino , Persona de Mediana Edad , Antro Pilórico , Radiografía , Neoplasias Gástricas/cirugía , Neoplasias Gástricas/terapiaRESUMEN
BACKGROUND: We aimed to investigate the efficacy of infliximab, a chimeric TNF-alpha antibody, in the prevention of fibrosis in an experimental alkaline burn of the oesophagus in the rat. METHODS: Thirty-two Wistar albino rats divided into four experimental groups. Caustic oesophageal burn was induced by applying 37.5% NaOH to the distal oesophagus. Infliximab was given at a dose of 5 mg/kg via the intraperitoneal route. Group A (sham) animals were uninjured, group B had untreated oesophageal burns, group C had oesophageal burns treated with a single dose of infliximab on the first day, and Group D had oesophageal burns treated with infliximab on the first and 14th days. Efficacy of the treatment was assessed on the 28th-day by measuring stenosis index of the oesophagus and histopathological damage score, and biochemically by determining tissue hydroxyproline content. RESULTS: There was no significant difference between the Group B and the infliximab treated Groups C and D in means of tissue hydroxyproline content and histopathological damage scores. Stenosis index was not significantly different between the Group B, Group C, and Group D. CONCLUSION: Anti-TNF-alpha treatment with infliximab does not ameliorate the degree of fibrosis in alkali burns of the oesophagus in the rat. Further evaluation of inflammatory and immunological events leading to stricture in alkaline oesophageal burns may provide new perspectives for the treatment of alkaline oesophageal burns.
Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Quemaduras Químicas/tratamiento farmacológico , Esófago/lesiones , Álcalis , Animales , Cáusticos , Modelos Animales de Enfermedad , Estenosis Esofágica/prevención & control , Infliximab , Distribución Aleatoria , Ratas , Ratas WistarRESUMEN
Five infants with congenital lobar emphysema whose main symptoms included dyspnea, cyanosis and recurrent respiratory infections, are presented herein. The most reliable diagnostic tool was plain chest X-ray films with antero-posterior and lateral views, while radio-isotopic investigation of the lung perfusion state took second place in the diagnosis of this disease. The affected lobes were the left upper lobe in four patients and the right middle lobe in one. Lobectomy was performed with good results in 4 patients, however, 1 infant was lost following an emergency thoracotomy.
Asunto(s)
Enfisema Pulmonar/congénito , Femenino , Humanos , Lactante , Masculino , Neumonectomía , Enfisema Pulmonar/diagnóstico por imagen , Enfisema Pulmonar/patología , Enfisema Pulmonar/cirugía , RadiografíaRESUMEN
AIM: In this study we aimed to clarify the role of mast cells in the development and progression of inflammation in cerulein-induced acute pancreatitis (AP) in rats. We have also examined the effects of ketotifen; a mast-cell stabilizing agent in the treatment of acute pancreatitis and its relation with nitric oxide (NO) synthesis. METHODS: In the first part of the study we planned to examine the effects mast cell stabilization in acute pancreatitis, while the second part was focused on examining the relation between NO synthesis and the potential effects of ketotifen in AP. Wistar albino rats were randomly divided into 6 groups (n: 10). In the first part of the study, AP was induced by four subcutaneous (sc) injections of 20 microg/kg body weight of cerulein at hourly intervals in Groups A and B while Group C was treated with saline as the control group. Group B was pretreated with ketotifen 1 mg/kg (ip). In the second part, the study design was similar except for the inhibition of nitric oxide synthesis by N-nitro L-arginine methyl ester (L-NAME) 30 mg/kg (ip) in Groups D, E and F. Group D was treated with L-NAME and cerulein and Group E was treated with ketotifen, L-NAME and cerulein. Group F was treated with L-NAME and saline as the control group. Serum amylase activity and pancreatic myeloperoxidase activity (MPO) were measured. Pancreatic histology and mast-cell count in pancreatic tissue were evaluated. RESULTS: Mast cell count was found to be increased in the pancreatic tissue in cerulein-induced AP. (2.93+/-0.26 vs 1.98+/-0.26; p<0.001). Ketotifen treatment significantly reduced cerulein induced edema (1.30+/-0.21 vs 0.70+/-0.15; p<0.001), neutrophil infiltration (1.50+/-0.16 vs 0.60+/-0.16; p<0.001) and attenuated the increase in amylase (4394.0+/-149.5 U/L vs 3350.5+/-216.9 U/L; p<0.05) and MPO activity (1.14+/-0.13 U/gr tissue vs 0.54+/-0.08 U/gr tissue; p<0.001). Mast-cell count in pancreatic tissue was also decreased significantly with ketotifen pretreatment (2.93+/-0.26 vs 1.70+/-0.21; p<0.05). Inhibition of NO synthesis with L-NAME treatment decreased the beneficial effects of ketotifen. CONCLUSION: It seems likely that mast cell activity may play an important role in the initiation and progression of acute pancreatitis. Ketotifen treatment may reduce the severity of AP in rats. The protective action of ketotifen in cerulein-induced acute pancreatitis is most probably owing to mast cell stabilization and stimulation of NO synthesis.
Asunto(s)
Ceruletida , Mastocitos/fisiología , Pancreatitis/inducido químicamente , Pancreatitis/fisiopatología , Enfermedad Aguda , Animales , Antialérgicos/uso terapéutico , Quimioterapia Combinada , Inhibidores Enzimáticos/uso terapéutico , Cetotifen/uso terapéutico , Masculino , Mastocitos/efectos de los fármacos , Mastocitos/patología , NG-Nitroarginina Metil Éster/uso terapéutico , Pancreatitis/tratamiento farmacológico , Pancreatitis/patología , Ratas , Ratas WistarRESUMEN
Sixteen patients with xanthogranulomatous pyelonephritis (XGP) are reported. The preoperative diagnosis of XGP may be difficult because of its clinical and radiological similarities to various other renal lesions, but in four patients XGP was suspected pre-operatively. Nephrectomy is necessary in most patients, although medical treatment may help a few.